About this trial
This protocol establishes a centralized stool donor bank and research platform to support microbiota transplantation therapy (MTT) for microbiota-mediated diseases. The study will characterize donor microbiome, metabolite, immune, and dietary profiles.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Any person aged 18-80 years of age, inclusive at the time of signing the consent
In good general health as evidenced by medical history
Disqualifiers
Inflammatory bowel disease
Enteric infections
Previous infection with Clostridium difficile
History of gastrointestinal surgery: Participants with gastrointestinal surgeries below the pylorus will be excluded from this protocol, including participants with a history of colectomy, segmental colonic resection, and small bowel resections.
Trial population
Eligible participants will be at least 18-years of age, generally healthy, and living in the San Francisco Bay Area.
Trial design
Cohort
Prospective
Treatments tested in this trial
Microbiome bank
Other interventionThis is an observational study with no interventions.
Treatment groups
Trial outcomes
Primary outcomes
Donor Eligibility Rate
Proportion of screened individuals who meet eligibility criteria for stool donation
Secondary outcomes
Microbiome Diversity of Donors
Alpha diversity (e.g., Shannon index) of stool samples from eligible donors
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Sean Spencer
Lead sponsor
Stanford University
Sponsor institution
Kepner Microbiome Fund
Collaborator
Mischa Deeter Research Fund
Collaborator
GI Diseases Fund
Collaborator
This trial is not recruiting at the moment. You can still explore other options: